20/06/2024 Healthcare
Satnic-60 Injection contains Artesunate IP, an effective antimalarial medication recommended by the WHO for severe malaria cases. Administered intravenously, it rapidly clears Plasmodium parasites from the bloodstream, reducing mortality rates. Satnic-60 Injection is crucial in regions with multidrug-resistant malaria strains, ensuring swift treatment and recovery. Its formulation is tailored for emergency situations, providing essential support in combating severe malaria infections where prompt intervention is critical for patient survival.Available in PCD Franchise for injectable range and third party manufacturing.
H&I Critical Care offers excellent opportunities in the Critical Care Injectable PCD segment with innovative and high-quality injectable products....
Maya Biotech is a leading dry injection manufacturer in India, delivering high-quality sterile formulations for hospitals, clinics, and pharmaceutical...
Smayan Healthcare is a trusted Liquid Injection Manufacturer in India, offering high-quality sterile injectable formulations produced in WHO-GMP compl...
OneKrit offers a wide range of high-quality critical care injections. Our critical care injectables are designed for emergency and intensive care use,...
More Details